Article
Development of Dengue virus type 2 replicons capable of prolonged expression in host cells
24 Aug 2001
Abstract excerpt
BACKGROUND: As part of a program to develop a Dengue virus vaccine which avoids the deleterious effects of antibody dependent enhancement (ADE) of infection mediated by antibodies to Dengue virus structural proteins, we have begun to investigate the possibility of designing Dengue vaccines based on non-structural proteins. RESULTS: Dengue constructs which lack major structural proteins replicate intracellularly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
